Essay On Revision Of Draft 2

<Student Name>
<Name and Section # of course>
<Instructor Name>

Introduction

Today, numerous individuals undergo serious illnesses that can cause prolonged pain and suffering. In order to alleviate them from their ailment, scientists and researchers have thoroughly worked on chronic illnesses and figured out cures and treatments for these diseases. One of the most painful and serious diseases is that of the kidney and the pursuing treatment for it that requires intense measures.

Literature Review

Li. Y and Wingert have mentioned the pros and cons of getting a kidney transplant which is the most common treatment of kidney disease. Chronic diseases related to kidney have been very common. Moreover, kidney transplantation has not turned up to be an easy technique since the transplanted organ is rejected by the recipient body. In addition, the limitations of this process and the cost implied by the health care system lower the efficacy of this technique. Consequently, researchers have pointed out the use of stem cells for the treatment of kidney ailments. Also, the identification of renal diseases through biomarkers, and the treatment possible by targeting particular cells can bring advancement to the ailments cure (Li & Wingert, 2013).
Contradicting this, Piccin and Orshead have stated the drawbacks of stem cell treatment. the stem cells technique possesses a drawback. Stem cells although can be active for most of an individual life span but the environmental changes can affect these cells leading to the regenerative inability (Piccin & Orshead, 2010).
Raggi and Berardi suggest the alternate method of using regenerative medicine. Regenerative medicine is required for the stem cells to work efficiently in the human body for long life. Therefore, the abnormality which causes lack of regenerative ability in stem cells associated with age should be studied profoundly in order to develop the regenerative medicine (Raggi & Berardi,2012). 
De Wert and Mummery, further point out the ethical issues related to stem cell transplant, which raises an alarm in some cultures. The research pertaining to stem cells involves the destruction of an embryo Moreover, the assumption that the acceptance of stem cells treatment can lead to adaptation of many unethical practices become the barrier to the introduction of stem cells into medical field. However, these ethical points are unjustified (De Wert & Mummery, 2003). This is supported by Bobrow, who restates the dangers related to the criminalization in research, considers the ethical points to be unfair. (Bobrow, 2005).
The issue related to stem cell transplant is two-fold; where on the one hand it is an expensive treatment, that can run out on its efficacy with changes in the environment and on the other hand it questions the ethical values of a society that bears this practice amongst kidney patients.
The decision lies with the policy-making organizations whether they wish to implement this treatment in hospitals for those who can afford it, or they simply work on regenerative medicinal treatment for their patients.

References

Bobrow, J. C. (2005). The Ethics and Politics of Stem Cell Research. Transactions of the
American Ophthalmological Society, 103, 138-142. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447568/ on 4th February 2015.
De Wert, G., & Mummery, C. (2003). Human embryonic stem cells: Research, ethics and policy.
Human Reproduction, 18(4), 672-682. Retrieved from humrep.oxfordjournals.org/content/18/4/672.short on 4th February 2015.
Li, Y., & Wingert, R. A. (2013). Regenerative medicine for the kidney: stem cell prospects &
challenges. Clin Transl Med, 2(11). Retrieved from http://www.biomedcentral.com/content/pdf/2001-1326-2-11.pdf on 4th February 2015.
Piccin, D., & Morshead, C. M. (2010). Potential and pitfalls of stem cell therapy in old age.
Disease models & mechanisms, 3(7-8), 421-425. Retrieved from
http://dmm.biologists.org/content/3/7-8/421.short on 4th February 2015.Raggi, C., & Berardi, A. C. (2012). Mesenchymal stem cells, aging and regenerative medicine.
Muscles, ligaments and tendons journal, 2(3), 239. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666525/ on 4th February 2015.